Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Pharmacyclics updates Xcytrin clinical trial progress

July 25, 2000

Photofrin distribution agreement established

July 25, 2000

Vion begins phase I trial of intravenous TAPET at Royal Marsden Hospital

July 25, 2000

Licensing opportunity from Immunex: interleukin-15 (IL-15)

July 24, 2000

Yeda presents new agents for PDT of tumors

July 24, 2000

Combination therapy with G-3139 and dacarbazine as new approach to malignant melanoma

July 24, 2000

Titan acquires novel agent for the treatment of cancer and viral disease

July 24, 2000

Valtaxin approved in Canada for CIS of the bladder

July 24, 2000

NeoPharm seeks clearance to begin clinical development of LE-AON

July 21, 2000

SB presents new inhibitors of a cell cycle-regulating kinase

July 21, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...